Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR known ✓ | P00533 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.93 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6705186 | 1.00 | — | — | |
| SCHEMBL4458 | 0.96 | — | — | |
| SCHEMBL28210447 | 0.93 | — | — | |
| SCHEMBL27469274 | 0.93 | HSP90AA1 (0.93) | HSP90AA1EGFRKDM4ECYP3A4 | |
| Hydrochloric Acid SCHEMBL360708 | 0.93 | — | — | |
| SCHEMBL854885 | 0.93 | — | — | |
| Formaldehyde SCHEMBL3745731 | 0.87 | — | — | |
| Boric Acid SCHEMBL8843854 | 0.84 | HSP90AA1 (0.77) | HSP90AA1 | |
| SCHEMBL578041 | 0.84 | HSP90AA1 (0.77) | HSP90AA1 | |
| SCHEMBL8156139 | 0.82 | HSP90AA1 (0.72) | HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1521805-B1 | AMINOPLAST MOLDING COMPOUNDS FOR PRODUCTS EXHIBITING AN IMPROVED FLEXIBILITY AND AMINOPLAST PRODUCTS EXHIBITING AN IMPROVED FLEXIBILITY | BOREALIS AGROLINZ MELAMINE (AT) | 2014-05-21 | — | — | EP | claimed |
| CN-100351287-C | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-11-28 | — | — | CN | claimed |
| CN-100345887-C | Pre-impregnating agents for high-resistant and elastic composite fibres | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-10-31 | — | — | CN | claimed |
| EP-1603969-B1 | PRE-IMPREGNATING AGENTS FOR HIGH-RESISTANT AND ELASTIC COMPOSITE FIBRES | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-10-03 | — | — | EP | claimed |
| EP-1448671-B1 | PRODUCTS, ESPECIALLY MOULDING MATERIALS OF POLYMERS CONTAINING TRIAZINE SEGMENTS, METHOD FOR THE PRODUCTION THEREOF AND USES OF THE SAME | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-09-12 | — | — | EP | claimed |
| US-20070048522-A1 | Prepregs for fiber composites having high strength and resilience | AMI - AGROLINZ MELAMINE INTERNATIONAL GMBH (AT) | 2007-03-01 | — | — | US | claimed |
| US-20060100317-A1 | Aminoplast molding compounds for products exhibiting an improved flexibility and aminoplast products exhibiting and improved flexibility | AMI - AGROLINZ MELAMINE INTERNATIONAL GMBH (AT) | 2006-05-11 | — | — | US | claimed |
| CN-1761705-A | Pre-impregnating agents for high-resistant and elastic composite fibres | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2006-04-19 | — | — | CN | claimed |
| CN-1615330-A | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2005-05-11 | — | — | CN | claimed |
| US-20050038226-A1 | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | BOREALIS AG (AT) | 2005-02-17 | — | — | US | claimed |
| EP-2044135-A1 | THERMOPLASTICALLY PROCESSABLE THERMOSET MOLDING MATERIALS WITH IMPROVED PROPERTY SPECTRUM | AMI Agrolinz Melamine International GmbH (AT) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008009464-A1 | THERMOPLASTICALLY PROCESSABLE THERMOSET MOLDING MATERIALS WITH IMPROVED PROPERTY SPECTRUM | AMI AGROLINZ MELAMINE INTERNATIONAL GMBH (AT) | 2008-01-24 | — | — | WO | disclosed |
| CN-100351287-C | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-11-28 | — | — | CN | disclosed |
| CN-100345887-C | Pre-impregnating agents for high-resistant and elastic composite fibres | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-10-31 | — | — | CN | disclosed |
| CN-100345887-C | Pre-impregnating agents for high-resistant and elastic composite fibres | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2007-10-31 | — | — | CN | disclosed |
| CN-1615330-A | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | AMI AGROLINZ MELAMINE INT GMBH (AT) | 2005-05-11 | — | — | CN | disclosed |
| US-20050038226-A1 | Products, especially moulding materials of polymers containing triazine segments, method for the production thereof and uses of the same | BOREALIS AG (AT) | 2005-02-17 | — | — | US | disclosed |
| WO-2004083288-A1 | PRE-IMPREGNATING AGENTS FOR HIGH-RESISTANT AND ELASTIC COMPOSITE FIBRES | AMI AGROLINZ MELAMINE INTERNATIONAL GMBH (AT) | 2004-09-30 | — | — | WO | disclosed |
| US-20040110758-A1 | 4,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2004-06-10 | — | — | US | disclosed |
| WO-2004031184-A1 | 4,6-DIAMINOSUBSTITUTED-2-[OXY OR AMINOXY]-[1,3,5]TRIAZINES AS PROTEIN TYROSINE KINASE INHIBITORS | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, INC. (US) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110758-A1 | 4,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors | TIE1, KDR, FLT1 | EGFR 20/4885HSP90AA1 3448/4885KDM4E 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.